Oral huangqi formulae for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wu, Lei ^a   Chen, Yuanbin ^a   Xu, Yinji ^a   Guo, Xinfeng ^a   Li, Xiaoyan ^a   Zhang, Anthony Lin ^b   May, Brian H ^b   Xue, Charlie Changli ^a,b   Wen, Zehuai ^a,c   Lin, Lin ^a  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b RMIT UNIVERSITY   (Australia)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CARBOCISTEINE; CHINESE DRUG; EXPECTORANT AGENT; HERBACEOUS AGENT; HUANGQI FORMULA; HYDROCHLORIC ACID; IPRATROPIUM BROMIDE; SALBUTAMOL; THEOPHYLLINE; UNCLASSIFIED DRUG;

ASTRAGALUS MEMBRANACEUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; META ANALYSIS; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; SPIROMETRY; SYMPTOM; SYSTEMATIC REVIEW;

EID: 84876560044     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/705315     Document Type: Review

References (46)

1. GOLD, Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2010, http://www.goldcopd
2. Lopez A. D., Murray C. C., The global burden of disease, 1990-2020. Nature Medicine 1998 4 1241 1243 (Pubitemid 28512100)
3. Zhong N., Wang C., Yao W., Chen P., Kang J., Huang S., Chen B., Wang C., Ni D., Zhou Y., Liu S., Wang X., Wang D., Lu J., Zheng J., Ran P., Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. American Journal of Respiratory and Critical Care Medicine 2007 176 8 753 760 2-s2.0-35348970821 10.1164/rccm.200612-1749OC (Pubitemid 47598476)
4. Fang X., Wang X., Bai C., COPD in China: the burden and importance of proper management. Chest 2011 139 4 920 929 2-s2.0-79953752611 10.1378/chest.10-1393
5. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S., Conway W. A., Enright P. L., Kanner R. E., O'Hara P., Owens G. R., Scanlon P. D., Tashkin D. P., Wise R. A., Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the lung health study. Journal of the American Medical Association 1994 272 19 1497 1505 2-s2.0-0027962628 10.1001/jama.272.19.1497 (Pubitemid 24340791)
6. Vestbo J., Sørensen T., Lange P., Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999 353 9167 1819 1823 2-s2.0-0033614639 10.1016/S0140-6736(98)10019-3 (Pubitemid 29251012)
7. Xu L. S., The influence of combined treatment of traditional Chinese medicine and western medicine on pulmonary function with the patients of moderate and severe COPD. China and Foreign Medical Journal 2007 5 2 55 56
8. Hong M. L., Gao L. Y., Dai S. Z., The effects of Yufeining on respiratory muscle strength and central respiratory drive in patients with COPD. Chinese Journal of Information on Traditional Chinese Medicine 2004 11 11 961 963
9. Jia G. L., Tong F. J., Yu D. Z., The clinical study of Yiqihuoxue combined ipratropium bromide inhalation in the treatment of chronic obstructive pulmonary disease. Zhejiang Journal of Traditional Chinese Medicine 2007 42 9 510 511
10. Wang S., Ji H. Y., Zhang N. Z., Zhuo X. Z., Zhao L. P., Zhu H. Z., Chen W., Ren W., Effect of yifei jianpi recipe on inflammatory cells, levels of interleukin-8 and tumor necrosis factor-alpha in sputum from patients with chronic obstructive pulmonary disease. Chinese Journal of Integrated Traditional and Western Medicine 2005 25 2 111 113 2-s2.0-21844443906
11. Cui Z. B., Yuan Y. D., Liu S. H., Intervention effect of tongfei mixture on nocturnal hypoxia in patients with chronic obstructive pulmonary disease. Chinese Journal of Integrated Traditional and Western Medicine 2004 24 10 885 888 2-s2.0-16644392753
12. Lin L., Tang C. Y., Xu Y. J., Clinical observation of spleen-lung nourishing granule in treating respiratory muscle fatigue of stable chronic obstructive pulmonary disease. Shanghai Journal of Traditional Chinese Medicine 2003 37 11 10 12
13. Zhang M. X., Clinical research on stable COPD treated by Jianpi Yifei Bushen method. Chinese Journal of Information on Traditional Chinese Medicine 2006 13 7 64 65
14. Feng X. Z., Yao H. Q., Clinical research on Jianpi Bufei method combined with western medicine in treating stable chronic obstructive pulmonary disease in 36 cases. Qinghai Medical Journal 2006 36 9 82 83
15. Zhao W., Luo F. M., He C. Q., Effects of lung rehabilitation and Bushen Chinese herbs in treating stable chronic obstructive pulmonary disease with lung function and quality of life. Modern Journal of Integrated Traditional Chinese and Western Medicine 2003 12 24 2643 2644
16. Li Y. Q., Yang C. X., Clinical research on stable COPD treated by Bufei Huoxue method. Beijing Journal of Traditional Chinese Medicine 2006 25 11 643 645
17. Xu D. S., He C. Y., Effect of Fufang Qiqi Decoction on prevention and treatment of chronic obstructive pulmonary diseases. Chinese Archives of Traditional Chinese Medicine 2004 22 6 991 992
18. Luo X. F., Chai X. J., Chen Y. M., Clinical research on Bufei Dingchuan Decoction in treating 36 cases of chronic obstructive pulmonary disease. Journal of Traditional Chinese Medicine 2002 43 4 268 270
19. Wang Y. F., Clinical research of Bufei Yishen capsule in treating COPD. Shandong Journal of Traditional Chinese Medicine 2007 47 13 30 31
20. Huang G., Clinical validation of Butihuatan decoction in treating lung spleen kidney qi deficiency with the patients of COPD [M.S. Dissertation] 2008 Guiyang University of TCM
21. He Y. C., Chen H. L., Zhang R. F., Clinical research on quality of life of oral Buzhongyiqi in chronic obstructive pulmonary disease. Chinese Archives of Traditional Chinese Medicine 2010 28 3 506 507
22. Guan Q. H., Therapy of Chinese medicine of Qixu Xueyu Tanzu syndrome of COPD and research of molecular biology index on airway remodeling [Doctor's Dissertation] 2006 Beijing University of Chinese Medicine
23. Wei B., Cui S. F., Zheng Y. X., Yiqi Huayu Decoction treatment of 60 cases of respiratory muscle fatigue syndrome. Shanxi Journal of Traditional Chinese Medicine 2007 28 12 1590 1591
24. Ma J. M., Meng Z. R., Yin J. C., Role of Bufei Tang in the recovery treatment of stable chronic obstructive pulmonary disease. Chinese Journal of Hospital Pharmacy 2010 30 5 404 406
25. Ding Y. H., Yuan C. Y., Buyi Feishen Decoction treatment of stable chronic obstructive pulmonary disease. Heilongjiang Journal of Traditional Chinese Medicine 2009 5 24 25
26. Zhou Y. F., Jing Y. X., Clinical research on the effects of treating chronic obstructive pulmonary disease with Feisaitong Heji [Master's Dissertation] 2005 Shandong University of Traditional Chinese Medicine
27. Hu C. Q., Jiajian Bufei Decoction combined with western medicine treatment of 35 cases of stable chronic obstructive pulmonary disease. Journal of TCM Research 2009 22 11 24 26
28. Chen Q., Xu C., Cai Y., Ye L., Clinical research of combined treatment of traditional Chinese medicine and western medicine on chronic obstructive pulmonary disease. Journal of Fujian University of TCM 2009 19 4 12 14
29. Liang A. W., Huang M. X., Gu L. X., Effect of Dongpingtang with TCM theory "winter disease being cured in summer" on pulmonary function and quality of life in patients with chronic obstructive pulmonary disease in stable stage. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 2009 19 6 333 336
30. Zhang B. M., Shen Z.X., Peng S.F., Yifei Yangyin decoction on the treatment of chronic obstruction pulmonary disease. Chinese Journal of Ethnomedicine and Ethnopharmacy 2009 18 24 159 160
31. Japan Society for Oriental Medicine EBM special committee, 2002 median reports: evidence-based medicine (EBM) reports on Chinese prescriptions. Japanese Journal of Oriental Medicine 2002 53 5 1 80
32. WHO Regional Office for the Western Pacific., WHO international standard terminologies on traditional medicine in the western pacific region. WPRO Nonserial Publication 2007
33. Group of Chronic Obstructive Pulmonary Diseases. Committee of Respiratory Disease. Chinese Medical Association, Guideline for diagnosis and treatment of chronic obstructive pulmonary disease (2007). Chinese Journal of Tuberculosis and Respiratory Disease 2007 30 1 8 17
34. Zheng X. Y., Guidance for Clinical Research on New Drugs of TCM 2002 China Medical Science Press
35. Higgins J. P. T., Altman D. G., Higgins J. P. T., Green S., Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 2008 The Cochrane Collaboration. http://handbook.cochrane.org/
36. Wang Z., Zhang Y. H., Xu Q. Q., Several methods of publication bias evaluation. Chinese Journal of Health Statistics 2009 26 539 541
37. Schulz K. F., Altman D. G., Moher D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 2010 152 11 726 732 2-s2.0-77953395873
38. Currie G. P., Douglas J. G., ABC of chronic obstructive pulmonary disease: Non-pharmacological management. British Medical Journal 2006 332 7554 1379 1381 2-s2.0-33744967474 (Pubitemid 44365357)
39. George J., Ioannides-Demos L. L., Santamaria N. M., Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Medical Journal of Australia 2004 181 5 248 251 2-s2.0-4544333234 (Pubitemid 39247882)
40. Liu Z. G., Li Z. G., Peng B., Plasma metabonomic studies on the stable phase chronic obstructive pulmonary disease patients of Fei-qi deficiency syndrome and the Chinese materia medica intervention. Chinese Journal of Integrated Traditional and Western Medicine 2011 31 12 1619 1626
41. Yang Y., Hou J. S., Chi H. J., Huangqi chronic obstructive pulmonary disease rat airway inflammation intervention function experimental research. Shandong Medicine 2010 50 20 49 51
42. Li Q., Research progress of pharmacological effects of Huangqi. Medicine Industry Information 2006 3 11 128 129
43. Chen L., Sun B. B., Wang T., Wang X., Li J. Q., Wang H. X., Zhang S. F., Liu D. S., Liu L., Xu D., Ou X. M., Chen Y. J., Yang T., Zhou H., Wen F. Q., Cigarette smoke enhances β -defensin 2 expression in rat airways via nuclear factork- B activation. European Respiratory Journal 2010 36 3 638 645 2-s2.0-77956580787 10.1183/09031936.00029409
44. Yuan X., Sun S., Wang S., Sun Y., Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma. Planta Medica 2011 77 4 328 333 2-s2.0-79952486447 10.1055/s-0030- 1250408
45. Guo R., Pittler M. H., Ernst E., Herbal medicines for the treatmet of COPD: a systematic review. European Respiratory Journal 2006 28 2 330 338 2-s2.0-33845505486 10.1183/09031936.06.00119905 (Pubitemid 44914232)
46. An X., Zhang A. L., Yang A. W., Lin L., Wu D., Guo X., Shergis J. L., Thien F. C. K., Worsnop C. J., Xue C. C., Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respiratory Medicine 2011 105 2 165 176 2-s2.0-78651397481 10.1016/j.rmed.2010.11.007